| Primary |
| Sinusitis |
31.4% |
| Bronchitis |
23.8% |
| Pneumonia |
6.4% |
| Upper Respiratory Tract Infection |
6.3% |
| Hypertension |
4.7% |
| Cough |
3.3% |
| Drug Use For Unknown Indication |
2.7% |
| Respiratory Tract Infection |
2.6% |
| Pain |
2.4% |
| Acute Sinusitis |
2.2% |
| Pharyngitis |
2.1% |
| Bronchitis Acute |
1.8% |
| Tonsillitis |
1.8% |
| Asthma |
1.7% |
| Lyme Disease |
1.6% |
| Ear Infection |
1.1% |
| Pyrexia |
1.1% |
| Chronic Sinusitis |
1.0% |
| Depression |
1.0% |
| Diabetes Mellitus |
1.0% |
|
| Vomiting |
25.6% |
| Vision Blurred |
12.1% |
| Weight Decreased |
9.8% |
| Pyrexia |
6.8% |
| White Blood Cell Count Increased |
6.3% |
| Hepatitis |
4.4% |
| Hepatic Enzyme Increased |
4.2% |
| Liver Function Test Abnormal |
4.2% |
| Visual Disturbance |
3.8% |
| Nausea |
2.9% |
| Injury |
2.5% |
| Urticaria |
2.4% |
| Jaundice |
2.4% |
| Malaise |
2.1% |
| Respiratory Failure |
2.0% |
| Hepatic Failure |
1.7% |
| Rash |
1.7% |
| Yellow Skin |
1.7% |
| Drug Ineffective |
1.6% |
| Visual Acuity Reduced |
1.6% |
|
| Secondary |
| Bronchitis |
27.7% |
| Sinusitis |
23.6% |
| Asthma |
8.9% |
| Cough |
8.8% |
| Pneumonia |
4.3% |
| Muscle Spasms |
3.0% |
| Pain |
3.0% |
| Respiratory Tract Infection |
2.8% |
| Drug Use For Unknown Indication |
2.7% |
| Upper Respiratory Tract Infection |
2.6% |
| Hypertension |
2.0% |
| Glossitis |
1.8% |
| Pharyngitis |
1.4% |
| Tonsillitis |
1.4% |
| Pharyngolaryngeal Pain |
1.1% |
| Gastrointestinal Disorder |
1.1% |
| Acute Sinusitis |
1.0% |
| Lung Infection |
1.0% |
| Chronic Sinusitis |
0.9% |
| Pyrexia |
0.9% |
|
| Vomiting |
26.3% |
| Weight Decreased |
16.8% |
| Lymphadenopathy |
14.6% |
| Urine Phosphate Increased |
5.9% |
| Respiratory Failure |
5.8% |
| White Blood Cell Count Increased |
5.1% |
| Splenomegaly |
3.9% |
| Pyrexia |
3.3% |
| Vision Blurred |
2.6% |
| Injury |
2.3% |
| Stomach Discomfort |
2.2% |
| Transaminases Increased |
2.2% |
| Liver Function Test Abnormal |
1.6% |
| Urosepsis |
1.3% |
| Yellow Skin |
1.3% |
| Staphylococcal Sepsis |
1.1% |
| Hepatitis C |
1.0% |
| Weight Increased |
1.0% |
| Hepatocellular Damage |
0.9% |
| Hyperhidrosis |
0.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
16.6% |
| Drug Use For Unknown Indication |
14.9% |
| Foetal Exposure During Pregnancy |
7.4% |
| Pain |
5.6% |
| Breast Cancer |
4.8% |
| Hypercholesterolaemia |
4.7% |
| Asthma |
4.5% |
| Chronic Obstructive Pulmonary Disease |
4.3% |
| Crohn's Disease |
4.3% |
| Non-hodgkin's Lymphoma |
3.7% |
| Respiratory Tract Infection |
3.7% |
| Bronchitis |
3.5% |
| Ill-defined Disorder |
3.5% |
| Eczema |
3.4% |
| Hypertension |
2.8% |
| Depression |
2.6% |
| Sinusitis |
2.6% |
| Sleep Disorder |
2.6% |
| Headache |
2.4% |
| Anxiety |
2.0% |
|
| Weight Decreased |
10.0% |
| White Blood Cell Count Increased |
8.9% |
| Vomiting |
7.8% |
| Weight Increased |
7.8% |
| Skin Ulcer |
6.7% |
| Postmenopause |
5.6% |
| Pyrexia |
5.6% |
| Suicide Attempt |
5.6% |
| Ventricular Fibrillation |
5.6% |
| Pulmonary Embolism |
4.4% |
| Uterine Leiomyoma |
4.4% |
| Deafness Neurosensory |
3.3% |
| Deep Vein Thrombosis |
3.3% |
| Injury |
3.3% |
| International Normalised Ratio Increased |
3.3% |
| Supraventricular Tachycardia |
3.3% |
| Tenosynovitis |
3.3% |
| Type 2 Diabetes Mellitus |
3.3% |
| Cardiac Failure |
2.2% |
| Convulsion |
2.2% |
|
| Interacting |
| Drug Use For Unknown Indication |
27.3% |
| Product Used For Unknown Indication |
18.2% |
| Hiv Infection |
13.6% |
| Antibiotic Therapy |
9.1% |
| Metastatic Renal Cell Carcinoma |
9.1% |
| Pain |
9.1% |
| Lung Disorder |
4.5% |
| Respiratory Tract Infection |
4.5% |
| Tachyarrhythmia |
4.5% |
|
| Somnolence |
25.0% |
| Toxic Skin Eruption |
25.0% |
| Hypoglycaemic Coma |
12.5% |
| International Normalised Ratio Decreased |
12.5% |
| International Normalised Ratio Increased |
12.5% |
| Lung Disorder |
12.5% |
|
